Most prescription drugs manufactured overseas—are they safe?

Most pharmaceutical drugs in Canada are manufactured overseas in countries such as India, China and others, yet how can we be confident the drug supply is safe, writes a drug policy researcher in an opinion piece in CMAJ (Canadian Medical Association Journal).

Alarmed by alerts about potentially harmful products such as nonprescription erectile dysfunction drugs with names like Uprizing 2.0 and Ying Da Wang—most from overseas—Alan Cassels began to think about sold in Canada. Are they safe? Who regulates them?

"Most Canadians probably don't know that many of our pharmaceuticals come from places like India and China," writes Cassels. "How often do our regulators dust off their passports and fly to China or India to ensure that the plants producing pharmaceuticals are clean, follow proper manufacturing techniques and contain what is on the label (and nothing else)?"

He was unable to find out much from Health Canada because information about inspections is not public.

"This situation doesn't leave me with the warm fuzzies," he writes. "Especially when we're dealing with—how can I say this nicely—a federal agency that refuses to even enforce the laws against illegal on a bus shelter at the end of my street?"

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.120416

add to favorites email to friend print save as pdf

Related Stories

Female feticide in Canada requires action

Jan 16, 2012

Canada should prohibit disclosure of the sex of a fetus until after 30 weeks of pregnancy to combat female feticide which is practised by some ethnic groups in Canada and the United States, states an editorial in CMAJ (Canad ...

Pharmaceutical intellectual property laws need reform

Nov 07, 2011

Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation in developing new drugs, states an analysis in CMAJ (Canadian Medical Association Journal).

Recommended for you

Protalix signs supply deal with Brazilian govt

15 hours ago

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...

EU fines pharma firms over generics delay (Update)

15 hours ago

(AP)—The European Union has fined Danish pharmaceuticals multinational Lundbeck and several other producers a combined 146 million euros ($195 million) for delaying the market entry of cheaper generic alternatives ...

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

US doctors' group labels obesity a disease

(HealthDay)—In an effort to focus greater attention on the weight-gain epidemic plaguing the United States, the American Medical Association has now classified obesity as a disease.